Greater China Digest: GL Ventures co-leads Thousand Oaks round; Taiwan’s Influenxio bags $2m

Thousand Oaks Biopharmaceuticals has raised over 400 million yuan ($61 million) in its Series C round of financing co-led by China State-Owned Capital Venture Investment Fund and GL Ventures, while Taipei-based Influenxio has garnered $2 million from DCM Ventures.